Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +2.76% | -21.16% | -24.75% |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
Apr. 30 | Top Premarket Decliners | MT |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 52.47 |
Enterprise Value (EV) 1 | 26.74 |
P/E ratio | 6.19 x |
Yield | - |
Capitalization / Revenue | 1.32 x |
EV / Revenue | 0.67 x |
EV / EBITDA | 2.06 x |
EV / FCF | -2,684,198 x |
FCF Yield | -0% |
Price to Book | 0.85 x |
Nbr of stocks (in thousands) | 26,500 |
Reference price 2 | 1.980 |
Announcement Date | 4/4/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 31.6 | 30.67 | 34.3 | 33.8 | 39.76 |
EBITDA 1 | 10.48 | 9.593 | 12.05 | 11.35 | 13.01 |
EBIT 1 | 9.728 | 8.787 | 11.3 | 10.65 | 12.26 |
Operating Margin | 30.78% | 28.65% | 32.94% | 31.5% | 30.83% |
Earnings before Tax (EBT) 1 | 9.733 | 8.996 | 11.51 | 10.74 | 11.59 |
Net income 1 | 7.07 | 6.407 | 8.462 | 7.818 | 8.338 |
Net margin | 22.37% | 20.89% | 24.67% | 23.13% | 20.97% |
EPS 2 | 0.3142 | 0.2848 | 0.3761 | 0.3475 | 0.3198 |
Free Cash Flow | - | 6.243 | 5.913 | 8.297 | -9.963 |
FCF margin | - | 20.36% | 17.24% | 24.54% | -25.06% |
FCF Conversion (EBITDA) | - | 65.08% | 49.07% | 73.11% | - |
FCF Conversion (Net income) | - | 97.44% | 69.88% | 106.13% | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 10/28/21 | 10/28/21 | 5/2/22 | 5/1/23 | 4/4/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 5.08 | 8.33 | 16.5 | 22.3 | 25.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | 6.24 | 5.91 | 8.3 | -9.96 |
ROE (net income / shareholders' equity) | - | 24.9% | 26.2% | 20.1% | 16.3% |
ROA (Net income/ Total Assets) | - | 17.7% | 18.5% | 14.9% | 13.7% |
Assets 1 | - | 36.25 | 45.71 | 52.55 | 60.98 |
Book Value Per Share 2 | 1.050 | 1.230 | 1.640 | 1.830 | 2.320 |
Cash Flow per Share 2 | 0.2400 | 0.3900 | 0.7500 | 1.000 | 0.9800 |
Capex 1 | 4.74 | - | 0.03 | 1.95 | 7.8 |
Capex / Sales | 15% | - | 0.08% | 5.77% | 19.62% |
Announcement Date | 10/28/21 | 10/28/21 | 5/2/22 | 5/1/23 | 4/4/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-24.75% | 56.25M | |
+1.14% | 6.83B | |
-.--% | 62.2M | |
-22.06% | 59.8M |
- Stock Market
- Equities
- LICN Stock
- Financials Lichen China Limited